Home600196 • SHA
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs A
Previous close
¥24.65
Day range
¥24.51 - ¥25.85
Year range
¥20.38 - ¥30.44
Market cap
59.16B CNY
Avg Volume
17.50M
P/E ratio
37.06
Dividend yield
1.06%
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 10.31B | -2.08% |
Operating expense | 4.21B | -11.29% |
Net income | 615.06M | -22.19% |
Net profit margin | 5.97 | -20.51% |
Earnings per share | — | — |
EBITDA | 1.32B | 28.06% |
Effective tax rate | 16.35% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 16.10B | -7.04% |
Total assets | 115.54B | 3.03% |
Total liabilities | 56.68B | -0.03% |
Total equity | 58.86B | — |
Shares outstanding | 2.67B | — |
Price to book | 1.40 | — |
Return on assets | 1.51% | — |
Return on capital | 1.86% | — |
Cash Flow
Net change in cash
(CNY) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 615.06M | -22.19% |
Cash from operations | 989.69M | 5.65% |
Cash from investing | -1.46B | 34.43% |
Cash from financing | 991.93M | -11.27% |
Net change in cash | 516.49M | 941.63% |
Free cash flow | 1.63B | 119.01% |
About
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Founded
1994
Website
Employees
39,309